Effective management of CMV infection in pediatric and adult patients

May 14, 2019

The new Siemens Healthineers CMV IgG assay offers an aid in the determination of serological status and the diagnosis of CMV infection in individuals for whom a CMV IgG test was ordered, including pregnant women.

The new Atellica IM/ADVIA Centaur CMV IgG Assay can (a) produce faster results and reduce costs by reducing repeat testing with no equivocal zone; (b) achieve accuracy when determining CMV IgG patient serological status with a positive agreement of 99.6 percent and a negative agreement of 96.8 percent; and (c) reach a broader patient population at risk for CMV, with both adult and pediatric claims.

Visit Siemens Healthineers for more information